Updated hourlyHourly refreshWed, Oct 7, 2026
Press Release Database
Recent press releases, indexed by topic.
Finance · Healthcare
SOUTH JORDAN, Utah, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2026, after the close of the stock market on Thursday, October 29, 2026. Merit plans to hold its investor conference call on the same day (Thursday, October 29, 2026) at 4:30 p.m. Eastern (3:30 p.m. Central, 2:30 p.m. Mountain, and 1:30 p.m. Pacific).
Oct 6 · 20:30·GlobeNewswire
Finance
New initiative equips parish leaders to identify community needs, develop sustainable responses, and access up to $25,000 in funding HUNTINGTON, Ind., Oct. 6, 2026 /PRNewswire/ -- The OSV Institute for Catholic Innovation has launched CorWorks, a new initiative designed to help Catholic...
Oct 6 · 20:29·PR Newswire
Finance
AXIL Brands, Inc. Reports First Quarter Fiscal 2027 Financial Results
Oct 6 · 20:20·GlobeNewswire
Finance · AI
SRX to dividend ETF holdings to shareholders
Oct 6 · 20:20·GlobeNewswire
Finance
DALLAS, Oct. 6, 2026 /PRNewswire/ -- VineBrook Homes Trust, Inc. ("VineBrook Homes" or the "Company") announced today the preliminary results of its previously announced tender offer (the "Offer") to purchase shares of the Company's Class A common stock, par value $0.01 per share (the...
Oct 6 · 20:20·PR Newswire
Finance
Final antidumping and countervailing duty orders on Chinese van-type trailers and subassemblies follow affirmative Commerce and ITC determinations; Section 232 steel and aluminum tariffs continue to apply to imported trailers Final antidumping and countervailing duty orders on Chinese van-type trailers and subassemblies follow affirmative Commerce and ITC determinations; Section 232 steel and aluminum tariffs continue to apply to imported trailers
Oct 6 · 20:18·GlobeNewswire
Finance
ST. LOUIS PARK, Minn., October 06, 2026--Bridgewater Bancshares, Inc. (Nasdaq: BWB), the parent company of Bridgewater Bank, today announced that it will release its third quarter 2026 financial results after the market closes on Tuesday, October 20, 2026.
Oct 6 · 20:15·mlpr-businesswire
Finance
MALVERN, Pa., Oct. 06, 2026 (GLOBE NEWSWIRE) -- CubeSmart (NYSE: CUBE) today announced that the Company will release financial results for the three-month period ended September 30, 2026 after the market close on Thursday, October 29, 2026. An accompanying conference call will be held at 11:00 a.m. ET on Friday, October 30, 2026.
Oct 6 · 20:15·GlobeNewswire
Finance · Real Estate
SAN MATEO, Calif., October 06, 2026--Essex Property Trust, Inc. (NYSE:ESS) announced today that it plans to release its third quarter 2026 earnings after the market closes on Tuesday, October 27, 2026. A conference call with senior management is scheduled for Wednesday, October 28, 2026 at 9:00 a.m.
Oct 6 · 20:15·mlpr-businesswire
Finance · Energy
THE WOODLANDS, Texas, October 06, 2026--Excelerate Energy, Inc. (NYSE: EE) (the "Company" or "Excelerate") will release its third quarter 2026 results on Wednesday, November 4, 2026, following the close of U.S. financial markets.
Oct 6 · 20:15·mlpr-businesswire
Finance
LANSING, Mich., October 06, 2026--Jackson Financial Inc.1 (NYSE: JXN) (Jackson®) today announced that it will release third quarter 2026 financial results after market close on Tuesday, November 3, 2026. Jackson’s press release and supplemental financial materials will be available at investors.jackson.com.
Oct 6 · 20:15·mlpr-businesswire
Finance · Healthcare
WALTHAM, Mass., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma , Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that the independent Compensation Committee of its Board of Directors approved the grant of options to purchase an aggregate of 81,525 shares of the Company’s ordinary shares to six non-executive employees as equity inducement awards under the Crescent Biopharma, Inc. 2025 Employment Inducement Incentive Award Plan, as amended (the “Inducement Plan”). The options were approved on October 5, 2026 and were material to each employee's acceptance of employment with Crescent, in accordance with Nasdaq Listing Rule 5635(c)(4).
Oct 6 · 20:15·GlobeNewswire